These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9876562)

  • 21. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation of an intermediate product from human serum albumin for the production of a solid dosage form.
    Kristó K; Bajdik J; Eros I; Dékány I; Pallai Z; Pintye-Hódi K
    Eur J Pharm Biopharm; 2008 Mar; 68(3):741-6. PubMed ID: 17870448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extrusion/spheronization: an important method for the production of the pellet dosage form].
    Häring A; Rabisková M
    Ceska Slov Farm; 2007 Jan; 56(1):11-6. PubMed ID: 17432276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microencapsulation studies on aminophylline involving spherical crystallization, spheronization and drug loading on to non-pareil seeds.
    Boles MG; Deasy PB; Donnellan MF
    J Microencapsul; 1994; 11(1):55-67. PubMed ID: 8138875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.
    Abbaspour MR; Sadeghi F; Garekani HA
    Int J Pharm; 2005 Oct; 303(1-2):88-94. PubMed ID: 16153792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pelletization of melts and liquids].
    Rabisková M
    Ceska Slov Farm; 2011 Apr; 60(2):54-60. PubMed ID: 21650006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting optimal wet granulation parameters for extrusion-spheronisation of pharmaceutical pellets using a mixer torque rheometer.
    Kuhs M; Moore J; Kollamaram G; Walker G; Croker D
    Int J Pharm; 2017 Jan; 517(1-2):19-24. PubMed ID: 27915006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach.
    Varca GH; Lopes PS; Ferraz HG
    Drug Dev Ind Pharm; 2015 Mar; 41(3):430-5. PubMed ID: 24410044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation of cores for the controlled release of glucose for prevention of hypoglycemia in diabetes patients.
    Franc A; Dvořáčková K; Muselík J; Zvaková M; Slováková V; Vetchý D; Sabadková D; Neumann D; Goněc R
    Ceska Slov Farm; 2014 Oct; 63(5):206-12. PubMed ID: 25354740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function.
    Singh G; Pai RS; Devi VK
    J Young Pharm; 2012 Jul; 4(3):146-56. PubMed ID: 23112533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spheronization process particle kinematics determined by discrete element simulations and particle image velocimentry measurements.
    Koester M; García RE; Thommes M
    Int J Pharm; 2014 Dec; 477(1-2):81-7. PubMed ID: 25304094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Croscarmellose Sodium as Pelletization Aid in Extrusion-Spheronization.
    Siebel F; Kleinebudde P
    AAPS PharmSciTech; 2024 Jun; 25(6):147. PubMed ID: 38937406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical model for in vitro drug release from controlled release dosage forms applied to propoxyphene hydrochloride pellets.
    Christensen FN; Hansen FY; Bechgaard H
    J Pharm Sci; 1982 Jun; 71(6):694-9. PubMed ID: 7097537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of wet packability of component particles in pellet formation.
    Sarkar S; Wong TW; Liew CV
    AAPS PharmSciTech; 2013 Sep; 14(3):1267-77. PubMed ID: 23955149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design.
    Singh G; Pai RS; Devi VK
    J Adv Pharm Technol Res; 2012 Jan; 3(1):30-40. PubMed ID: 22470891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of particle size and coating level on the diffuse reflectance of wax matrices.
    Dredán J; Zelkó R; Antal I; Bihari E; Rácz I
    J Pharm Pharmacol; 1998 Feb; 50(2):139-42. PubMed ID: 9530980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling and optimization of a pharmaceutical formulation system using radial basis function network.
    Anand P; Siva Prasad BV; Venkateswarlu Ch
    Int J Neural Syst; 2009 Apr; 19(2):127-36. PubMed ID: 19496208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimization of cataplasm matrix with face-centered design-response surface method].
    Liu S; Li J; Jin R; Du M
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3211-3. PubMed ID: 20353002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Wetting agent dosage screening for traditional Chinese medicine pellet based on torque rheological property].
    Li X; Hong YL; Xian JC; Feng Y; Zheng YP; Chu SC
    Zhongguo Zhong Yao Za Zhi; 2017 Sep; 42(17):3341-3349. PubMed ID: 29192444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process analytical technology (PAT) approach to the formulation of thermosensitive protein-loaded pellets: Multi-point monitoring of temperature in a high-shear pelletization.
    Kristó K; Kovács O; Kelemen A; Lajkó F; Klivényi G; Jancsik B; Pintye-Hódi K; Regdon G
    Eur J Pharm Sci; 2016 Dec; 95():62-71. PubMed ID: 27577010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.